Clinical Trial Update: A Multi-Country Observational Study of Safety and Effectiveness of Elfabrio® in Fabry Patients

View source ↗

Summary

A multi-country observational study evaluating the safety and effectiveness of Elfabrio (migalastat) in Fabry disease patients, sponsored by Chiesi Farmaceutici…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Fabry Disease

Drugs mentioned

• Elfabrio (migalastat)

Snippet

Sponsor: Chiesi Farmaceutici S.p.A. | Conditions: Fabry Disease | Status: RECRUITING